IN8BIO, INC. — Director's Dealing 2024

Feb 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-02-07

Reporting Person: Ho William Tai-Wei (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-07	Employee Stock Option (right to buy)	$1.22	A	502000	Acquired	2034-02-07	Common Stock (502000)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on February 7, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.